Reshma Rani Thadani, MD
Pediatrics · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Thadani’s office at (650) 330-7400 to ask if they take your plan before you enroll.
California Medical Board record
Licence A90054 · Current
Licensed to practise in California · since 2005 · expires 2027-02-28 · Hahnemann University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatrics
Medicaid work
$378,006 in 2024
Medicaid paid $378,006 for 6,308 billed services this clinician did in 2024, up to 120 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 916 | $364,850 |
| Return visit (30+ min) | 639 | $3,089 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 144 | $1,396 |
| Application of topical fluoride | 126 | $1,308 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 813 | $1,240 |
| Developmental screening | 76 | $1,206 |
| SARSCOV CORONAVIRUS AG IA | 46 | $1,157 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 76 | $800 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 141 | $799 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 149 | $785 |
| Short return visit (20+ min) | 227 | $492 |
| Screening test, pure tone, air only | 258 | $235 |
| 2024 | 6,308 | 30 | 120 | $378,006 |
| 2023 | 8,016 | 31 | 129 | $512,515 |
| 2022 | 6,565 | 27 | 148 | $351,578 |
| 2021 | 6,837 | 26 | 112 | $384,960 |
| 2020 | 4,196 | 21 | 121 | $365,289 |
| 2019 | 5,053 | 20 | 175 | $538,507 |
| 2018 | 1,633 | 19 | 149 | $173,705 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,301 | $507,456 |
| Return visit (30+ min) | 1,060 | $1,696 |
| SARSCOV CORONAVIRUS AG IA | 47 | $991 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 1,068 | $513 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 174 | $376 |
| Short return visit (20+ min) | 178 | $336 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 37 | $280 |
| Alcohol and/or drug screening | 25 | $216 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 70 | $190 |
| Screening test, pure tone, air only | 418 | $175 |
| OFF/OP EST MAY X REQ PHY/QHP | 14 | $64 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 407 | $63 |
2022
| Clinic visit/encounter, all-inclusive | 934 | $347,008 |
| Return visit (30+ min) | 879 | $1,719 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 898 | $651 |
| Alcohol and/or drug screening | 43 | $648 |
| Screening test, pure tone, air only | 382 | $345 |
| Short return visit (20+ min) | 171 | $342 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 42 | $171 |
| Screening for depression is documented as negative, a follow-up plan is not required | 18 | $158 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 230 | $147 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 41 | $98 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 340 | $96 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 418 | $81 |
2021
| Clinic visit/encounter, all-inclusive | 1,054 | $383,174 |
| Return visit (30+ min) | 639 | $405 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 164 | $384 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 227 | $216 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 799 | $209 |
| Screening test, pure tone, air only | 593 | $205 |
| Long return visit (40+ min) | 49 | $147 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 26 | $67 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 280 | $58 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 49 | $46 |
| HEMOGLOBIN | 461 | $38 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 64 | $11 |
2020
| Clinic visit/encounter, all-inclusive | 991 | $356,951 |
| Return visit (30+ min) | 558 | $5,346 |
| Short return visit (20+ min) | 201 | $1,032 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 205 | $700 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 147 | $512 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 71 | $232 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 64 | $223 |
| Screening test, pure tone, air only | 191 | $82 |
| HEMOGLOBIN | 387 | $67 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 46 | $54 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 144 | $46 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 32 | $33 |
2019
| Clinic visit/encounter, all-inclusive | 1,603 | $528,009 |
| Return visit (30+ min) | 691 | $6,417 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 297 | $1,305 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 97 | $873 |
| Short return visit (20+ min) | 522 | $810 |
| Screening test, pure tone, air only | 415 | $281 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 184 | $270 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 39 | $138 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 18 | $119 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 18 | $108 |
| HEMOGLOBIN | 395 | $68 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 14 | $67 |
2018
| Clinic visit/encounter, all-inclusive | 511 | $163,139 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 27 | $2,430 |
| Return visit (30+ min) | 105 | $1,813 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 16 | $1,440 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 101 | $908 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $900 |
| Unlisted preventive medicine service | 36 | $900 |
| Short return visit (20+ min) | 167 | $616 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 59 | $531 |
| OFF/OP EST MAY X REQ PHY/QHP | 82 | $418 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 13 | $144 |
| Varicella virus vaccine (VAR), live, for subcutaneous use | 13 | $144 |
Professional record
- NPI
- 1811000656
- Licence
- CA A90054California A90054: Current · expires 2027-02-28
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 300 Pasteur Dr, Sumc - Peds Physician Billing Mc: 5530, Stanford, CA, 94305
- NPI first listed
- 2006-08-16
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.